ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,199Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 2456

$606K Total Retail Price of All Prescriptions

Rank: 152 out of 2456

559 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 11,638 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 1,283 1,140 1 1
SIMVASTATIN 908 764 2 2
ATENOLOL 857 751 3 6
LEVOTHYROXINE SODIUM 647 556 4 4
OMEPRAZOLE 629 501 5 3
FUROSEMIDE 500 446 6 8
METFORMIN HCL 391 354 7 11
CITALOPRAM HBR 371 321 8 14
HYDROCHLOROTHIAZIDE 277 259 9 7
WARFARIN SODIUM 210 209 10 9
AMLODIPINE BESYLATE 207 178 11 5
METOPROLOL TARTRATE 195 188 12 10
DONEPEZIL HCL 168 168 13 23
GABAPENTIN 167 116 14 16
ZOLPIDEM TARTRATE 160 107 15 28
PROAIR HFA 155 106 16 22
TRAMADOL HCL 153 110 17 24
ADVAIR DISKUS 151 127 18 36
PAROXETINE HCL 150 107 19 56
METOPROLOL SUCCINATE 144 117 20 13
TERAZOSIN HCL 141 128 21 76
POTASSIUM CHLORIDE 140 118 22 33
HYDROCODONE-ACETAMINOPHEN 137 96 S3 23 20
GLIPIZIDE 137 128 23 46
DILTIAZEM 24HR ER 136 128 25 78
PANTOPRAZOLE SODIUM 129 86 26 37
ATORVASTATIN CALCIUM 125 97 27 12
PRAVASTATIN SODIUM 123 112 28 15
FELODIPINE ER 122 109 29 130
OXYCODONE-ACETAMINOPHEN 120 33 S2 30 35
CLOPIDOGREL 119 102 31 55
CIPROFLOXACIN HCL 113 84 32 87
FLUTICASONE PROPIONATE 110 76 33 30
TAMSULOSIN HCL 99 99 34 32
PREDNISONE 99 72 34 39
RANITIDINE HCL 98 85 36 31
AZITHROMYCIN 91 72 37 60
ALPRAZOLAM 91 91 37 141
KLOR-CON 10 91 81 37 133
DICLOFENAC SODIUM 90 53 40 189
GLYBURIDE 90 80 R 40 40
PLAVIX 88 73 42 79
DIGOXIN 78 78 43 49
DILTIAZEM ER 77 77 44 198
HYDRALAZINE HCL 69 63 45 105
OXYBUTYNIN CHLORIDE 69 57 45 152
AMITRIPTYLINE HCL 66 55 R 47 83
JANUVIA 62 62 48 81
ISOSORBIDE MONONITRATE ER 61 59 49 48
TRIAMCINOLONE ACETONIDE 60 49 50 131
KLOR-CON M10 59 57 51 196
LANTUS 59 46 51 44
LORAZEPAM 58 45 53 67
SPIRIVA 58 41 53 43
CYCLOBENZAPRINE HCL 58 19 R 53 77
METHOCARBAMOL 55 28 R 56 321
NAMENDA 54 54 57 42
LOVASTATIN 54 49 57 34
KLOR-CON M20 54 37 57 69
CARVEDILOL 52 52 60 54
INSULIN SYRINGE 51 47 61 72
CEPHALEXIN 50 40 62 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.